After a three-day pre-phase treatment (carboplatin [d1-3 - 100mg/m2] and etoposide [100mg/m2]) and the first cycle of PEB, the patient did not receive granulocyte colony-stimulating factor (G-CSF), as the risk of neutropenia is considered low with this regimen. The gene discussed is CSF3; the disease is neutropenia.